Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Nature Genetics

Volumn 40, Issue 12, 2008, Pages 1461-1465

  Romeo, Stefano ^a   Kozlitina, Julia ^a,b   Xing, Chao ^a   Pertsemlidis, Alexander ^a   Cox, David ^c   Pennacchio, Len A ^d,e   Boerwinkle, Eric ^f   Cohen, Jonathan C ^a   Hobbs, Helen H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b SOUTHERN METHODIST UNIVERSITY   (United States)

^c Perlegen Sciences Inc   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^e U S DEPARTMENT OF ENERGY   (United States)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; EUROPEAN AMERICAN; GENE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEPATITIS; HETEROZYGOTE; HISPANIC; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; NUCLEOTIDE SEQUENCE; PNPLA3 GENE; PRIORITY JOURNAL; RACE DIFFERENCE;

FATTY LIVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LIPASE; MALE; MEMBRANE PROTEINS;

EID: 56749096610     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.257     Document Type: Article

References (29)

1. Wang, M.Y. et al. Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome. Proc. Natl. Acad. Sci. USA 105, 6139-6144 (2008).
2. Browning, J.D. et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387-1395 (2004).
3. Browning, J.D. & Horton, J.D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114, 147-152 (2004).
4. McCullough, A.J. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin. Liver Dis. 8, 521-533 (2004).
5. Adams, L.A. et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113-121 (2005).
6. de Alwis, N.M. & Day, C.P. Non-alcoholic fatty liver disease: the mist gradually clears. J. Hepatol. 48 (Suppl. 1), S104-S112 (2008).
7. Browning, J.D., Kumar, K.S., Saboorian, M.H. & Thiele, D.L. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am. J. Gastroenterol. 99, 292-298 (2004).
8. Clark, J.M., Brancati, F.L. & Diehl, A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am. J. Gastroenterol. 98, 960-967 (2003).
9. Caldwell, S.H., Harris, D.M., Patrie, J.T. & Hespenheide, E.E. Is NASH underdiagnosed among African Americans? Am. J. Gastroenterol. 97, 1496-1500 (2002).
10. Victor, R.G. et al. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am. J. Cardiol. 93, 1473-1480 (2004).
11. Longo, R. et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J. Magn. Reson. Imaging 5, 281-285 (1995).
12. Szczepaniak, L.S. et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am. J. Physiol. Endocrinol. Metab. 288, E462-E468 (2005).
13. Hinds, D.A. et al. Whole-genome patterns of common DNA variation in three human populations. Science 307, 1072-1079 (2005).
14. Wilson, P.A., Gardner, S.D., Lambie, N.M., Commans, S.A. & Crowther, D.J. Characterization of the human patatin-like phospholipase family. J. Lipid Res. 47, 1940-1948 (2006).
15. Rydel, T.J. et al. The crystal structure, mutagenesis, and activity studies reveal that patatin is a lipid acyl hydrolase with a ser-asp catalytic dyad. Biochemistry 42, 6696-6708 (2003).
16. Strickland, J.A., Orr, G.L. & Walsh, T.A. Inhibition of Diabrotica larval growth by patatin, the lipid acyl hydrolase from potato tubers. Plant Physiol. 109, 667-674 (1995).
17. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study. Operations Manual No 2: Cohort Component Procedures. (ARIC Coordinating Center, School of Public Health, University of North Carolina, Chapel Hill, North Carolina, 1987).
18. Minehira, K. et al. Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. J. Lipid Res. 49, 2038-2044 (2008).
19. Monetti, M. et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 6, 69-78 (2007).
20. Baulande, S., Lassnier, F., Lucas, M. & Pairault, J. Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage. J. Biol. Chem. 276, 33336-33344 (2001).
21. Lake, A.C. et al. Expression, regulation, and triglyceride hydrolase activity of adiponutrin family members. J. Lipid Res. 46, 2477-2487 (2005).
22. 2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J. Biol. Chem. 279, 48968-48975 (2004).
23. Yuan, X. et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am. J. Hum. Genet. (in the press).
24. Rietz, S., Holk, A. & Scherer, G.F. Expression of the patatin-related phospholipase A gene AtPLA IIA in Arabidopsis thaliana is up-regulated by salicylic acid, wounding, ethylene, and iron and phosphate deficiency. Planta 219, 743-753 (2004).
25. Brown, S.A. et al. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected U.S. communities. Arterioscler. Thromb. 13, 1139-1158 (1993).
26. Falush, D., Stephens, M. & Pritchard, J.K. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164, 1567-1587 (2003).
27. Smith, M.W. et al. A high-density admixture map for disease gene discovery in African Americans. Am. J. Hum. Genet. 74, 1001-1013 (2004).
28. Zhu, X. et al. Admixture mapping for hypertension loci with genome-scan markers. Nat. Genet. 37, 177-181 (2005).
29. Romeo, S. et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat. Genet. 39, 513-516 (2007).